LRRK2 inhibitor 1
≥99%
- Product Code: 101290
CAS:
1802525-61-6
| Molecular Weight: | 397.43 g./mol | Molecular Formula: | C₂₀H₂₃N₅O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
LRRK2 inhibitor 1 is primarily used in research focused on understanding and treating Parkinson's disease. It specifically targets the LRRK2 kinase enzyme, which is implicated in the pathogenesis of the disease. By inhibiting this enzyme, it helps in studying the underlying mechanisms of neurodegeneration and potential therapeutic strategies. Additionally, it is utilized in preclinical studies to evaluate its efficacy and safety as a potential drug candidate for Parkinson's and other related disorders.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | €1,218.06 |
+
-
|
| 0.010 | 10-20 days | €2,030.09 |
+
-
|
LRRK2 inhibitor 1
LRRK2 inhibitor 1 is primarily used in research focused on understanding and treating Parkinson's disease. It specifically targets the LRRK2 kinase enzyme, which is implicated in the pathogenesis of the disease. By inhibiting this enzyme, it helps in studying the underlying mechanisms of neurodegeneration and potential therapeutic strategies. Additionally, it is utilized in preclinical studies to evaluate its efficacy and safety as a potential drug candidate for Parkinson's and other related disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :